Stem cell therapy in pulmonary arterial hypertension: current
practice and future opportunities
Ruixuan Zheng1,#, Mengyao Xie1,#,
Xinghong Wang1, Lehe Yang1,*, Jian
Wang2,*, Xiaoying Huang1,*
1 Division of Pulmonary Medicine, The First Affiliated
Hospital, Wenzhou Medical University, Key Laboratory of Heart and Lung,
Wenzhou, Zhejiang 325000, China.
2 State Key Laboratory of Respiratory Disease,
National Clinical Research Center for Respiratory Disease, Guangdong Key
Laboratory of Vascular Disease, Guangzhou Institute of Respiratory
Health, the First Affiliated Hospital of Guangzhou Medical University,
Guangzhou, Guangdong, China
# These authors contribute equally to this work.
*Correspondence to:
Xiaoying Huang Professor and Lehe Yang Ph.D.
Division of Pulmonary Medicine, The First Affiliated Hospital, Wenzhou
Medical University, Wenzhou, Zhejiang 325000, China.
mail: huangxiaoying@wzhospital.cn and yanglehe@wmu.edu.com
Jian Wang Professor
State Key Laboratory of Respiratory Disease, National Clinical Research
Center for Respiratory Disease, Guangdong Key Laboratory of Vascular
Disease, Guangzhou Institute of Respiratory Health, the First Affiliated
Hospital of Guangzhou Medical University, 151 Yanjiang Road, Guangzhou,
Guangdong 510120, China.
E-mail: jiw037@ucsd.edu
Word count: 5411 words